Jan 23 (Reuters) - GENMAB:
* ANNOUNCES 2017 NET SALES FIGURES FOR DARZALEX® (DARATUMUMAB)
* ‍WORLDWIDE NET SALES OF DARZALEX (DARATUMUMAB) AS REPORTED BY JOHNSON & JOHNSON WERE USD 1,242 MILLION IN 2017​
* ‍NET SALES WERE USD 884 MILLION IN U.S. AND NET SALES IN REST OF WORLD WERE USD 358 MILLION​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)
 